解剖病理学市场规模、份额、成长分析、按产品、按应用、按最终用途、按地区 - 行业预测，2025-2032 年

2023年解剖病理市场规模为377.1亿美元，从2024年的404.6亿美元增长到2032年的703.2亿美元，在预测期内（2025-2032年）预计将以7.3%的复合年增长率增长。

由于临床生物标记越来越多地用于疾病发展，以加强临床决策和改善患者治疗结果，预计全球解剖病理学市场将出现强劲增长。这种需求正在进一步增加，特别是在印度和中国等开发中国家，基于生物标记的病理测试正在变得越来越普遍，先进技术正在引进。病理检测设备（包括数位显微镜和染色系统）的显着进步也有助于市场扩张。特别是像 OptraSCAN 这样的公司正在透过智慧解决方案进行创新，以简化分析流程。皇家飞利浦和 Ibex Medical Analytics 等合作旨在将人工智慧融入病理学，促进创新并扩大产品系列，确保该行业在整个预测期内持续成长。

目录

介绍

• 研究目的
• 调查范围
• 定义

调查方法

• 资讯采购
• 二手资料和主要资料方法
• 市场规模预测
• 市场假设与限制

执行摘要

• 全球市场展望
• 供需趋势分析
• 按细分市场的机会分析

市场动态及展望

• 市场概况
• 市场规模
• 市场动态
  • 驱动因素和机会
  • 抑制因素和挑战
• 波特的分析

主要市场考察

• 关键成功因素
• 竞争程度
• 主要投资机会
• 生态系绘图
• 市场吸引力指数（2024年）
• PESTEL分析
• 总体经济指标
• 价值链分析
• 价格分析
• 案例研究
• 技术评估
• 监管环境
• 管道分析
• 疾病流行病学
• 专利分析

解剖病理学市场规模：按产品和服务分类

• 市场概况
• 装置
  • 玻片染色系统
  • 组织处理系统
  • 细胞处理器
  • 切片机和低温恒温器
  • 嵌入系统
  • 盖拖鞋
  • 其他产品
• 消耗品
  • 抗体
  • 一抗
  • 二抗
  • 试剂套件和试剂
  • 污垢和溶剂
  • 稳定剂
  • 其他套件和试剂
  • 探测
  • 其他消耗品
• 服务
  • 组织病理学服务
  • 细胞病理服务

解剖病理学市场规模：依应用分类

• 市场概况
• 疾病诊断
  • 癌症
  • 乳癌
  • 消化道癌症
  • 肺癌
  • 摄护腺癌
  • 其他癌症
  • 其他疾病
• 医学调查
• 药物发现与开发
• 其他的

解剖病理学市场规模：依最终用途分类

• 市场概况
• 医院
• 临床实验室
• 诊断实验室
• 其他的

解剖病理学市场规模

• 北美洲
  • 美国
  • 加拿大
• 欧洲
  • 德国
  • 西班牙
  • 法国
  • 英国
  • 义大利
  • 其他欧洲国家地区
• 亚太地区
  • 中国
  • 印度
  • 日本
  • 韩国
  • 其他亚太地区
• 拉丁美洲
  • 巴西
  • 其他拉丁美洲地区
• 中东/非洲
  • 海湾合作委员会国家
  • 南非
  • 其他中东/非洲

竞争资讯

• 前5名企业对比
• 主要企业市场定位（2024年）
• 主要市场参与者所采取的策略
• 近期市场趋势
• 公司市场占有率分析（2024年）
• 主要企业简介
  • 公司简介
  • 产品系列分析
  • 按细分市场分類的份额分析
  • 收益与前一年同期比较（2022-2024）

主要企业简介

• F. Hoffman-LA Roche Ltd.
• Danaher Corporation
• PHC Holdings Corporation
• Abcam Plc.
• Hologic, Inc.
• Agilent Technologies
• Becton, Dickinson And Company
• Sakura Finetek Usa Inc.
• Merck Kgaa
• Bio SB
• Quest Diagnostics Incorporated
• Laboratory Corporation of America Holdings
• Cardinal Health
• NeoGenomics Laboratories, Inc.
• BioGenex
• Thermo Fisher Scientific Inc.
• Bio-Rad Laboratories, Inc.
• Siemens AG
• Cell Signaling Technology, Inc.
• PerkinElmer Inc.

结论和建议

Anatomic Pathology Market size was valued at USD 37.71 Billion in 2023 and is poised to grow from USD 40.46 Billion in 2024 to USD 70.32 Billion by 2032, growing at a CAGR of 7.3% during the forecast period (2025-2032).

The global anatomic pathology market is poised for robust growth, driven by the increased utilization of clinical biomarkers for disease pathogenesis, which enhances clinical decision-making and improves patient outcomes. The rising prevalence of biomarker-based pathology tests and advanced technology adoption, particularly in developing nations like India and China, further fuels this demand. Significant advancements in pathology equipment, including digital microscopes and staining systems, are also contributing to market expansion. Notably, companies like OptraSCAN are innovating with intelligent solutions to streamline analysis processes. Collaborations, such as that between Royal Philips and Ibex Medical Analytics, aim to integrate AI into pathology, fostering innovation and broadening product portfolios, thus ensuring continued growth in this sector through the forecast period.

Top-down and bottom-up approaches were used to estimate and validate the size of the Anatomic Pathology market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Anatomic Pathology Market Segmental Analysis

Global Anatomic Pathology Market is segmented by product, application, end use and region. Based on product, the market is segmented into instruments, consumables and services. Based on application, the market is segmented into disease diagnostics, medical research, drug discovery and development and others. Based on end use, the market is segmented into hospitals, clinical laboratories, diagnostic laboratories and others. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.

Driver of the Anatomic Pathology Market

The anatomic pathology market is poised for significant growth, primarily driven by the rising incidence of various chronic diseases and evolving consumer lifestyles and dietary habits. Our research indicates that the global population aged 65 and older was approximately 727 million in 2020 and is projected to double to 1.5 billion by 2050. This substantial increase in the elderly demographic is anticipated to generate considerable opportunities for the anatomic pathology market in the near future. As a result, the combination of demographic shifts and the growing burden of chronic conditions will be key factors propelling market expansion throughout the forecast period.

Restraints in the Anatomic Pathology Market

One significant restraint impacting the anatomic pathology market is the limited availability of refurbished anatomic pathology equipment globally. This scarcity poses a challenge, particularly for small and medium-sized hospitals and laboratories that prioritize cost-effectiveness in their investments. As these end users often opt for refurbished equipment to meet their budget constraints, the lack of supply in this segment is anticipated to hinder the overall growth of the anatomic pathology market during the projected period. Therefore, addressing the shortage of affordable, refurbished options is crucial for fostering a more robust market environment.

Market Trends of the Anatomic Pathology Market

The anatomic pathology market is experiencing a notable shift towards advanced technological solutions, driven by the increasing adoption of digital microscopes, staining systems, and gross imaging tools. These innovations offer enhanced accuracy and specificity compared to traditional methods, revolutionizing diagnostic processes. As healthcare providers seek to improve patient outcomes through more reliable and efficient pathology solutions, the demand for sophisticated anatomic pathology equipment is surging. This trend underscores a broader movement towards digitalization and automation in healthcare, presenting lucrative growth opportunities for manufacturers and service providers in the anatomic pathology sector over the next few years.

Table of Contents

Introduction

• Objectives of the Study
• Scope of the Report
• Definitions

Research Methodology

• Information Procurement
• Secondary & Primary Data Methods
• Market Size Estimation
• Market Assumptions & Limitations

Executive Summary

• Global Market Outlook
• Supply & Demand Trend Analysis
• Segmental Opportunity Analysis

Market Dynamics & Outlook

• Market Overview
• Market Size
• Market Dynamics
  • Drivers & Opportunities
  • Restraints & Challenges
• Porters Analysis
  • Competitive rivalry
  • Threat of substitute
  • Bargaining power of buyers
  • Threat of new entrants
  • Bargaining power of suppliers

Key Market Insights

• Key Success Factors
• Degree Of Competition
• Top Investment Pockets
• Ecosystem Mapping
• Market Attractiveness Index, 2024
• Pestel Analysis
• Macro-Economic Indicators
• Value Chain Analysis
• Pricing Analysis
• Case Studies
• Technology Assessment
• Regulatory Landscape
• Pipeline Analysis
• Disease Epidemiology
• Patent Analysis

Global Anatomic Pathology Market Size by Product & Services & CAGR (2025-2032)

• Market Overview
• Instruments
  • Slide Staining Systems
  • Tissue Processing Systems
  • Cell Processors
  • Microtomes & Cryostat
  • Embedding Systems
  • Cover Slippers
  • Other Products
• Consumables
  • Antibodies
  • Primary Antibodies
  • Secondary Antibodies
  • Kits And Reagents
  • Stains And Solvents
  • Fixatives
  • Other Kits and Reagents
  • Probes
  • Other Consumables
• Services
  • Histopathology Services
  • Cytopathology Services

Global Anatomic Pathology Market Size by Application & CAGR (2025-2032)

• Market Overview
• Disease Diagnostics
  • Cancer
  • Breast Cancer
  • Gastrointestinal Cancer
  • Lung Cancer
  • Prostate Cancer
  • Other Cancers
  • Other Diseases
• Medical Research
• Drug Discovery and Development
• Others

Global Anatomic Pathology Market Size by End Use & CAGR (2025-2032)

• Market Overview
• Hospitals
• Clinical Laboratories
• Diagnostic Laboratories
• Others

Global Anatomic Pathology Market Size & CAGR (2025-2032)

• North America (Product & Services, Application, End Use)
  • US
  • Canada
• Europe (Product & Services, Application, End Use)
  • Germany
  • Spain
  • France
  • UK
  • Italy
  • Rest of Europe
• Asia Pacific (Product & Services, Application, End Use)
  • China
  • India
  • Japan
  • South Korea
  • Rest of Asia-Pacific
• Latin America (Product & Services, Application, End Use)
  • Brazil
  • Rest of Latin America
• Middle East & Africa (Product & Services, Application, End Use)
  • GCC Countries
  • South Africa
  • Rest of Middle East & Africa

Competitive Intelligence

• Top 5 Player Comparison
• Market Positioning of Key Players, 2024
• Strategies Adopted by Key Market Players
• Recent Developments in the Market
• Company Market Share Analysis, 2024
• Company Profiles of All Key Players
  • Company Details
  • Product Portfolio Analysis
  • Company's Segmental Share Analysis
  • Revenue Y-O-Y Comparison (2022-2024)

Key Company Profiles

• F. Hoffman-LA Roche Ltd.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Danaher Corporation
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• PHC Holdings Corporation
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Abcam Plc.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Hologic, Inc.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Agilent Technologies
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Becton, Dickinson And Company
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Sakura Finetek Usa Inc.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Merck Kgaa
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Bio SB
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Quest Diagnostics Incorporated
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Laboratory Corporation of America Holdings
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Cardinal Health
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• NeoGenomics Laboratories, Inc.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• BioGenex
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Thermo Fisher Scientific Inc.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Bio-Rad Laboratories, Inc.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Siemens AG
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Cell Signaling Technology, Inc.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• PerkinElmer Inc.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments

Conclusion & Recommendations